Publications by authors named "Peter Meredith"

Claim this Profile
I
Importance of sustained and "tight" blood pressure control in patients with high cardiovascular risk.
Peter A Meredith, Suzanne M Lloyd, Ian Ford, Henry L Elliott

Blood Press· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic importance of pretreatment and on-treatment blood pressure: Further analysis of the ACTION database and the effect of nifedipine gastrointestinal therapeutic system.
Henry L Elliott, Suzanne M Lloyd, Ian Ford, Peter A Meredith

Blood Press· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acetaminophen use and risk of myocardial infarction and stroke in a hypertensive cohort.
Rachael L Fulton, Matthew R Walters, Ross Morton, Rhian M Touyz, Anna F Dominiczak, Peter A Meredith

Hypertension· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrapeutic equivalence in the treatment of hypertension: Can lercanidipine and nifedipine GITS be considered to be interchangeable?
Henry L Elliott, Peter A Meredith

World J Cardiol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term and ultra long-term blood pressure variability during follow-up and mortality in 14,522 patients with hypertension.
Claire E Hastie, Panniyammakal Jeemon, Holli Coleman, Linsay McCallum, Rajan Patel, Peter Meredith

Hypertension· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acetaminophen use and change in blood pressure in a hypertensive population.
Jesse Dawson, Rachael Fulton, Gordon T McInnes, Ross Morton, David Morrison, Peter Meredith

J Hypertens· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of the gastrointestinal therapeutic system (GITS) formulation and its effectiveness in the delivery of antihypertensive drug treatment (focus on nifedipine GITS).
Peter A Meredith, Henry L Elliott

Integr Blood Press Control· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are fixed-dose combination antihypertensives suitable as first-line therapy?
Sverre E Kjeldsen, Franz H Messerli, Chern-En Chiang, Peter A Meredith, Lisheng Liu

Curr Med Res Opin· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematocrit predicts long-term mortality in a nonlinear and sex-specific manner in hypertensive adults.
Laura Paul, Panniyammakal Jeemon, Jonathan Hewitt, Linsay McCallum, Peter Higgins, Peter Meredith

Hypertension· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: a literature review comparing amlodipine and nifedipine GITS.
Corey B Toal, Peter A Meredith, Henry L Elliott

Blood Press· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once daily nifedipine: the formulation dictates the pharmacokinetic characteristics and the therapeutic responses.
Corey B Toal, Peter A Meredith, Henry L Elliott

Int J Clin Pharmacol Ther· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving blood pressure control in patients with diabetes mellitus and high cardiovascular risk.
Henry L Elliott, Suzanne M Lloyd, Ian Ford, Peter A Meredith

Int J Hypertens· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensin-receptor blockade, cancer, and concerns.
Peter A Meredith, Gordon T McInnes

Lancet Oncol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits of nifedipine GITS in stable coronary artery disease: Further analysis of the "ACTION" database.
Peter A Meredith, Henry L Elliott

Adv Ther· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms.
Peter A Meredith

Curr Med Res Opin· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program.
Peter A Meredith, Jan Ostergren, Inder Anand, Margareta Puu, Scott D Solomon

J Am Coll Cardiol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationships between initial blood pressure and the response to different antihypertensive agents.
Peter A Meredith, Lilian S Murray, Gordon T McInnes

J Hypertens· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Candesartan cilexetil--a review of effects on cardiovascular complications in hypertension and chronic heart failure.
Peter A Meredith

Curr Med Res Opin· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensin II receptor antagonists alone and combined with hydrochlorothiazide: potential benefits beyond the antihypertensive effect.
Peter A Meredith

Am J Cardiovasc Drugs· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From hypertension to heart failure -- are there better primary prevention strategies?
Peter A Meredith, Jan Ostergren

J Renin Angiotensin Aldosterone Syst· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlled-release doxazosin as combination therapy in hypertension: the GATES study.
Henry R Black, Michael Keck, Peter Meredith, Kevin Bullen, Sheila Quinn

J Clin Hypertens (Greenwich)· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of long-term rilmenidine treatment in hypertensive diabetic patients. A retrospective analysis of a general practice study.
Peter A Meredith, John L Reid

Am J Cardiovasc Drugs· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydropyridine calcium channel blockers: basic pharmacological similarities but fundamental therapeutic differences.
Peter A Meredith, Henry L Elliott

J Hypertens· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A putative placebo comparison of the SCOPE and LIFE trials.
Peter A Meredith, Lilian S Murray, John J V McMurray, ,

J Renin Angiotensin Aldosterone Syst· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioequivalence and other unresolved issues in generic drug substitution.
Peter Meredith

Clin Ther· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis